Nutrien

Accelerating Regulations And Rising Carbon Costs Will Squeeze Margins

AnalystLowTarget

Not Invested

Consensus Narrative from 8 Analysts

Published

16 Jul 25

AnalystLowTarget's Fair Value

CA$66.36

20.1% overvalued

24 Jul

CA$79.67

28.6%

1.6%

28.6%

1.6%

Edit anytime before Jul 16 10:16 PM. Then post Updates to your followers.

Author's Valuation

CA$66.4

20.1% overvalued

AnalystLowTarget Fair Value

Narrative

Updates0

AnalystLowTarget Fair Value

CA$66.4

20.1% overvalued

Future estimation in

% p.a.

Decrease

Increase

Current revenue growth rate

2.25%

Chemicals revenue growth rate

0.68%

Risk Level (Discount Rate)

Our default considers factors like the company's size, volatility, profitablity and country of operation.

Decrease

Increase

Current discount rate

7.28%

Calculation

US$1.42b

Earnings '28

19.74x

PE Ratio '28

US$28.08b

Market Cap '28

US$28.08b

Market Cap '28

466.31m

No. shares '28

US$60.22

Share Price '28

US$60.22 Share Price '28

Discounted to 2025 @ 7.31% p.a.

US$48.73

Fair Value '25

US$48.73 Fair Value '25

Converted to CAD @ 1.3595 USD/CAD Exchange Rate

CA$66.25

Fair Value '25